Stock BCACU XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Xynomic Pharmaceuticals Holdings, Inc. Nasdaq

Equities

BCACU

VGG1142P1201

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Xynomic Pharmaceuticals Holdings, Inc. -.--% -19.05%
2021 Xu-Nuo Pharma, Inc. acquired the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc.. CI
2020 Xynomic Pharmaceuticals Holdings, Inc. Announces Resignation of Richard Peidong Wu as Independent Director and the Chairman of the Audit Committee CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CSL LIMITED Stock CSL Limited
 95.18B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 37.55B
BIOGEN INC. Stock Biogen Inc.
 33.75B
UCB Stock UCB
 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.63B
  1. Stock Market
  2. Equities
  3. XYN Stock
  4. BCACU Stock
  5. Charts Xynomic Pharmaceuticals Holdings, Inc.
  6. Sector Chart